Uric Acid and SGLT2 Inhibition With Empagliflozin in Heart Failure With Preserved Ejection Fraction: The EMPEROR-Preserved Trial.

Doehner W, Anker SD, Butler J, Zannad F, Filippatos G, Coats AJS, Ferreira JP, Henrichmoeller I, Brueckmann M, Schueler E, Pocock SJ, Januzzi JL, Packer M

Open source

DOI: 10.1016/j.jchf.2024.08.020
Published: 2024 Dec
Container: JACC. Heart failure
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jchf.2024.08.020,
  title = {Uric Acid and SGLT2 Inhibition With Empagliflozin in Heart Failure With Preserved Ejection Fraction: The EMPEROR-Preserved Trial.},
  author = {Doehner W and Anker SD and Butler J and Zannad F and Filippatos G and Coats AJS and Ferreira JP and Henrichmoeller I and Brueckmann M and Schueler E and Pocock SJ and Januzzi JL and Packer M},
  year = {2024},
  journal = {JACC. Heart failure},
  doi = {10.1016/j.jchf.2024.08.020},
  url = {https://doi.org/10.1016/j.jchf.2024.08.020}
}

RIS

TY  - JOUR
TI  - Uric Acid and SGLT2 Inhibition With Empagliflozin in Heart Failure With Preserved Ejection Fraction: The EMPEROR-Preserved Trial.
AU  - Doehner W
AU  - Anker SD
AU  - Butler J
AU  - Zannad F
AU  - Filippatos G
AU  - Coats AJS
AU  - Ferreira JP
AU  - Henrichmoeller I
AU  - Brueckmann M
AU  - Schueler E
AU  - Pocock SJ
AU  - Januzzi JL
AU  - Packer M
PY  - 2024
JO  - JACC. Heart failure
DO  - 10.1016/j.jchf.2024.08.020
UR  - https://doi.org/10.1016/j.jchf.2024.08.020
ER  -

APA

W, D., SD, A., J, B., F, Z., G, F., AJS, C., JP, F., I, H., M, B., E, S., SJ, P., JL, J., & M, P. (2024). Uric Acid and SGLT2 Inhibition With Empagliflozin in Heart Failure With Preserved Ejection Fraction: The EMPEROR-Preserved Trial.. JACC. Heart failure. https://doi.org/10.1016/j.jchf.2024.08.020

Source records

pubmed · retrieved 2026-09-26T05:41:23.675Z